LOS ANGELES and BOSTON, August 1, 2022 – Proskauer, a leading international law firm, is pleased to share that Partners Fangli Chen, Ph.D., Siegmund (Sige) Gutman and Bart Williams have been shortlisted by LMG Life Sciences for their 2022 Americas Awards. LMG Life Sciences ranks leading law firms and individuals in each practice area in the life sciences industry through deep analysis of the business and legal developments in the sector.
Fangli, Sige and Bart, all of whom sit within the Firm’s Litigation Department, were shortlisted for Patent Strategy Attorney of the Year – Massachusetts; General Patent Litigator of the Year – California; and Product Liability Attorney of the Year, respectively.
Fangli, who serves as vice-chair of the Firm’s Life Sciences Patent practice, represents companies across the biotech and pharmaceutical industries and brings a unique blend of patent prosecution, litigation expertise and deep scientific acumen. Her practice focuses on complex portfolio development, post-grant review before the USPTO, oppositions, pre-litigation and litigation strategy, due-diligence investigations, freedom-to-operate, non-infringement and invalidity analysis, licensing and other IP matters in connection with commercial transactions.
An accomplished trial lawyer and litigator, Sige is chair of the Firm’s Life Sciences Patent practice and a member of the Patent Law and Intellectual Property groups. He focuses his practice on developing and executing market exclusivity and freedom-to-operate strategies for leading biologics, pharmaceutical, biotechnology and medical device clients. Sige has extensive experience successfully litigating biologic drug patent and Hatch-Waxman cases, as well as in post-grant proceedings before the U.S. Patent and Trademark Office.
As one of the nation’s most sought after trial lawyers and commercial litigators, Bart has represented Fortune 500 corporations across life sciences and a range of other industries. He is a go-to lawyer for cases involving product liability and white-collar and government investigations and has secured numerous landmark victories for clients throughout his career.
We are 800+ lawyers serving clients from 12 offices located in the leading financial and business centers in the Americas, Europe and Asia. The world’s leading organizations, companies and corporations choose us to be their representatives in their most critical situations. But more, they consider Proskauer a strategic partner to drive their business forward. We work with asset managers, major sports leagues, Fortune 500 companies, entertainment industry legends and other industry-redefining companies.
Proskauer’s multidisciplinary Life Sciences Group brings together the critical skill sets and experience to litigate important intellectual property matters, create and grow life sciences companies, obtain intellectual property rights, raise capital and negotiate and execute strategic deals.
We represent mature pharma and biotech companies in accessing and protecting markets, early-to-later-stage companies in developing new medical technologies, investors in their strategic transactions, as well as universities and other academic or research institutions in realizing commercial value from the innovation of their faculty and research staff. The myriad connections we have in this sector allow us to help clients grow their businesses by gaining access to financing, technology, partners and markets. Working with clients at each stage of their development, our lawyers handle any challenges along the way. Whether raising capital, negotiating licensing agreements or terms of a sale or fighting back patent challenges, our team is equipped to help life sciences companies meet their business goals.